Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Molecular and Cellular Endocrinology|December 1, 1976
Effects of trypsin and phospholipases A2 and C on enzyme organization in testis microsomesL Bussmann, R A Huseby, L T Samuels
Cancer Research|July 1, 1975
Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testisG Kurland, A K Christensen, R A Huseby
Scandinavian Journal of Urology and Nephrology|January 1, 1988
Extraskeletal Ewing's sarcoma contiguous with the seminal vesicleT E Bjerklund Johansen, A Huseby, J T Stenwig
Cancer Research|June 1, 1984
Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cells in vivoR A Huseby, T M Maloney, C M McGrath
Cancer Research|January 1, 1988
Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasiaR L Juriansz, R A Huseby, R B Wilcox
Molecular and Cellular Endocrinology|March 1, 1980
Relation of membrane property of microsomes to androgen biosynthesisB Sato, K Nishikida, R A Huseby, et al.
Endocrinology|March 1, 1979
The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumorsB Sato, W Spomer, R A Huseby, et al.
Henry Ford Hospital Medical Journal|January 1, 1990
Evaluation of the predictive power of progesterone receptor levels in primary breast cancer: a comparison with other criteria in 559 cases with a mean follow-up of 74.8 months. The Breast Cancer Prognostic Study AssociatesR A Huseby, H E Ownby, S Brooks, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1976
Dehydrogenation of reduced pyridine nucleotides by Leydig cell tumors of the rat testisN A Schor, B F Rice, R A Huseby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1988
Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorshipR A Huseby, H E Ownby, J Frederick, et al.
Pageof 3